Cargando…
Replacing Needle Injection by a Novel Waterjet Technology Grants Improved Muscle Cell Delivery in Target Tissues
Current regimen to treat patients suffering from stress urinary incontinence often seems not to yield satisfactory improvement or may come with severe side effects. To overcome these hurdles, preclinical studies and clinical feasibility studies explored the potential of cell therapies successfully a...
Autores principales: | Geng, Ruizhi, Knoll, Jasmin, Harland, Niklas, Amend, Bastian, Enderle, Markus D., Linzenbold, Walter, Abruzzese, Tanja, Kalbe, Claudia, Kemter, Elisabeth, Wolf, Eckhard, Schenk, Martin, Stenzl, Arnulf, Aicher, Wilhelm K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036380/ https://www.ncbi.nlm.nih.gov/pubmed/35466714 http://dx.doi.org/10.1177/09636897221080943 |
Ejemplares similares
-
Injection of Porcine Adipose Tissue-Derived Stromal Cells by a Novel Waterjet Technology
por: Danalache, Marina, et al.
Publicado: (2021) -
Large Animal Models for Investigating Cell Therapies of Stress Urinary Incontinence
por: Amend, Bastian, et al.
Publicado: (2021) -
Regulation of Immune Checkpoint Antigen CD276 (B7-H3) on Human Placenta-Derived Mesenchymal Stromal Cells in GMP-Compliant Cell Culture Media
por: Amend, Bastian, et al.
Publicado: (2023) -
CD24: A Marker for an Extended Expansion Potential of Urothelial Cancer Cell Organoids In Vitro?
por: Geng, Ruizhi, et al.
Publicado: (2022) -
Elevated Expression of the Immune Checkpoint Ligand CD276 (B7-H3) in Urothelial Carcinoma Cell Lines Correlates Negatively with the Cell Proliferation
por: Harland, Niklas, et al.
Publicado: (2022)